Patent · US Active

Compounds for treatment of cancer

US11465987B2 · kind B2 · utility

0Cited by
22References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 20, 2016
Grant dateOct 11, 2022
Priority date
Expiry dateSep 20, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.